Show simple item record

dc.contributor.authorFuller, K
dc.contributor.authorMurphy, C
dc.contributor.authorFox, Simon
dc.contributor.authorKirstein, B
dc.contributor.authorChambers, TJ
dc.date.accessioned2023-02-15T15:40:26Z
dc.date.available2023-02-15T15:40:26Z
dc.date.issued2002-03-01
dc.identifier.issn0013-7227
dc.identifier.issn1945-7170
dc.identifier.urihttp://hdl.handle.net/10026.1/20395
dc.description.abstract

<jats:title>Abstract</jats:title><jats:p>TNFα is pivotal to the pathogenesis of inflammatory and possibly postmenopausal osteolysis. Much recent work has clarified mechanisms by which TNFα promotes osteoclastogenesis, but the means by which it activates osteoclasts to resorb bone remain uncertain. We found that very low concentrations of TNFα promoted actin ring formation, which correlates with functional activation in osteoclasts, both in osteoclasts formed in vitro and extracted from newborn rats. TNFα was equipotent with RANKL for this action. Activation by TNFα was unaffected by blockade of RANKL by OPG, its soluble decoy receptor, suggesting that this was due to a direct action on osteoclasts. Bone resorption was similarly directly and potently stimulated, in a RANKL-independent manner in osteoclasts, whether these were formed in vitro or in vivo. Interestingly, TNFα promoted actin ring formation at concentrations an order of magnitude below those required for osteoclastic differentiation. Moreover, TNFα strongly synergized with RANKL, such that miniscule concentrations of TNFα were sufficient to substantially augment osteoclast activation. The extreme sensitivity of osteoclasts to activation by TNFα suggests that the most sensitive osteolytic response of bone to TNFα is through activation of existing osteoclasts; and the strong synergy with RANKL provides a mechanism whereby increased osteolysis can be achieved without disturbance to the underlying pattern of osteoclastic localization.</jats:p>

dc.format.extent1108-1118
dc.format.mediumPrint
dc.languageen
dc.language.isoen
dc.publisherThe Endocrine Society
dc.subjectActins
dc.subjectAnimals
dc.subjectBone Marrow Cells
dc.subjectBone Resorption
dc.subjectCarrier Proteins
dc.subjectCell Separation
dc.subjectDrug Synergism
dc.subjectIndicators and Reagents
dc.subjectMale
dc.subjectMembrane Glycoproteins
dc.subjectMice
dc.subjectOsteoclasts
dc.subjectRANK Ligand
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectReceptor Activator of Nuclear Factor-kappa B
dc.subjectSpleen
dc.subjectTumor Necrosis Factor-alpha
dc.titleTNFα Potently Activates Osteoclasts, through a Direct Action Independent of and Strongly Synergistic with RANKL.
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/11861538
plymouth.issue3
plymouth.volume143 (3)
plymouth.publication-statusPublished
plymouth.journalEndrocrinology
dc.identifier.doi10.1210/endo.143.3.8701
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dc.identifier.eissn1945-7170
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1210/endo.143.3.8701
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV